HLB Panajin Posts 526 Million Won Operating Profit in First Half, Marks Two Consecutive Years in the Black
Revenue Reaches 6.82 Billion Won, Net Profit 2.04 Billion Won in First Half
Expanding PNA Materials Business
Responding to Growth in Nucleic Acid Therapeutics Market
Accelerating AOC Development
HLB Panajin announced on August 14 that it recorded separate financial results of 6.82 billion won in revenue, 526 million won in operating profit, and 2.04 billion won in net profit for the first half of this year. Operating profit remained in the black, following 749 million won in 2024 and 736 million won in 2025.
The company explained that increased interest in and expanded supply of PNA (peptide nucleic acid) materials had a positive impact on its performance. As the development of therapeutics directly targeting genes and RNA expands in the global nucleic acid therapeutics market, the applications of PNA materials are also broadening.
HLB Panajin is increasing its supply of materials based on its proprietary PNA technology and production capabilities. Having recently secured new contracts, the company is also expanding collaborations with local companies and research institutes in the United States, seeking new global business opportunities. Its strategy is to foster the PNA materials business as a new growth axis while maintaining stable revenues from its existing molecular diagnostics and materials businesses.
The company will also ramp up development of antibody-oligonucleotide conjugates (AOC) utilizing PNA technology. AOC is a technology that selectively delivers oligonucleotides to specific tissues or cells by attaching them to antibodies. HLB Panajin plans to increase research and development applying its proprietary PNA technology, thereby enhancing commercialization potential.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Chief Executive Officer Jang Ingeun of HLB Panajin stated, "As the global nucleic acid therapeutics market grows, interest in PNA technology and business opportunities are expanding," adding, "We will strengthen domestic and international sales of our PNA materials business, explore new business opportunities, and accelerate AOC development to achieve more tangible results in the second half of the year."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.